Athenex, Inc. (Nasdaq: ATNX) to Ring The Nasdaq Stock Market Closing Bell in Celebration of Its IPO
June 14 2017 - 6:00AM
What: Athenex, Inc. (Nasdaq:ATNX), an
innovative oncology company with drug discovery, drug formulation,
clinical development, and API/drug product manufacturing facilities
in both the U.S. and China, will visit the Nasdaq MarketSite in
Times Square in celebration of its initial public offering
(IPO).
In honor of the occasion, Johnson Y.N. Lau, CEO &
Board Chairman, will ring the Closing Bell.
Where:Nasdaq MarketSite – 4 Times Square – 43rd
& Broadway – Broadcast Studio
When:Wednesday, June 14, 2017 – 3:45 p.m. to
4:00 p.m. ET
Athenex Contact:Kerry Kelly(646)
541-9933Kerry.kelly@fticonsulting.com
Nasdaq MarketSite:Emily Pan(646)
441-5120emily.pan@nasdaq.com
Feed Information:Fiber Line (Encompass
Waterfront): 4463
Gal 3C/06C 95.05 degrees West 18 mhz Lower DL 3811 Vertical FEC
3/4 SR 13.235 DR 18.295411 MOD 4:2:0 DVBS QPSK
Social Media:For multimedia features such as
exclusive content, photo postings, status updates and video of bell
ceremonies, please visit our Facebook
page:http://www.facebook.com/NASDAQ.
For photos from ceremonies and events, please visit our
Instagram page:http://instagram.com/nasdaq
For livestream of ceremonies and events, please visit our
YouTube page:http://www.youtube.com/nasdaq/live
For news tweets, please visit our Twitter
page:http://twitter.com/nasdaq
For exciting viral content and ceremony photos, please visit our
Tumblr page:http://nasdaq.tumblr.com/
Webcast: A live stream of the Nasdaq Closing
Bell will be available at: https://new.livestream.com/nasdaq/live
or http://www.nasdaq.com/about/marketsitetowervideo.asx
Photos: To obtain a hi-resolution photograph of
the Market Close, please go to
http://business.nasdaq.com/discover/market-bell-ceremonies and
click on the market close of your choice.
About Athenex, Inc.Founded in 2003, Athenex,
Inc. is a global clinical stage biopharmaceutical company dedicated
to becoming a leader in the discovery and development of next
generation drugs for the treatment of cancer. Athenex is organized
around three platforms including an Oncology Innovation Platform, a
Commercial Platform and a Global Supply Chain Platform. Athenex’s
Oncology Innovation Platform generates clinical candidates through
an extensive understanding of kinases, including novel binding
sites, human absorption biology and through the application of
Athenex’s proprietary research and selection processes in the lab.
The Company’s current clinical pipeline is derived from two
different platform technologies Athenex calls Orascovery and Src
Kinase Inhibition. The Orascovery platform is based on the novel
oral P-glycoprotein pump inhibitor molecule HM30181A, through which
Athenex is able to facilitate oral absorption of traditional
cytotoxics, which Athenex believes may offer improved patient
tolerability and efficacy as compared to IV administration of the
same cytotoxics. The Src Kinase Inhibition platform refers to novel
small molecule compounds that have multiple mechanisms of action,
including the inhibition of the activity of Src Kinase and the
inhibition of tubulin polymerization during cell division. Athenex
believes the combination of these mechanisms of action provides a
broader range of anti-cancer activity as compared to either
mechanism of action alone. Athenex’s employees worldwide are
dedicated to improving the lives of cancer patients by creating
more active and tolerable treatments. Athenex has offices in
Buffalo and Clarence, New York, Cranford, New Jersey, Houston,
Texas, Chicago, Illinois, Hong Kong, Taipei Taiwan, and multiple
locations in Chongqing, China.
About NasdaqNasdaq (Nasdaq:NDAQ) is a leading
global provider of trading, clearing, exchange technology, listing,
information and public company services. Through its diverse
portfolio of solutions, Nasdaq enables customers to plan, optimize
and execute their business vision with confidence, using proven
technologies that provide transparency and insight for navigating
today's global capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 89
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to 3,800 total listings with a market
value of $11.0 trillion. To learn more, visit:
http://business.nasdaq.com.
-NDAQA-
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Mar 2024 to Apr 2024
Nasdaq (NASDAQ:NDAQ)
Historical Stock Chart
From Apr 2023 to Apr 2024
